Welcome to
our Blog
Here you can learn about the latest biometric developments for your sector
Welcome to
our Blog
Here you can learn about the latest biometric developments for your sector
Welcome to
our Blog
Here you can learn about the latest biometric developments for your sector
Fingerprints, faces or irises? We explore the features of the main biometric technologies
Biometrics offers a secure, convenient and fast way to identify people. We analyze the characteristics of the main biometric technologies, such as iris, facial and fingerprint recognition, considering the advantages and disadvantages they provide.
Ensuring the integrity of data collected in clinical trial EDCs with biometric technology
Ensuring the integrity of data collected in clinical trials is essential and represents a critical step in the introduction of new drugs to the market. The implementation of biometric electronic signatures in Electronic Data Capture (EDCs) ensures their accuracy and reliability.
Audit Trail to ensure data integrity in the pharmaceutical manufacturing process
The biometric electronic signature within the audit trail action log ensures the integrity of records in GMP regulated environments, providing detailed and reliable tracking of recorded activities.
Audit Trail to ensure data integrity in the pharmaceutical manufacturing process
The biometric electronic signature within the audit trail action log ensures the integrity of records in GMP regulated environments, providing detailed and reliable tracking of recorded activities.
GMP compliance in drug manufacturing
The pharmaceutical industry must ensure compliance with GMP regulations, which include a number of issues, including data integrity. The adoption of biometric technologies, such as iris or fingerprint recognition, emerges as the solution to ensure compliance.
GxP environments and their relevance to the pharmaceutical industry
Within GxP regulated environments, it is essential to ensure data integrity and traceability of actions throughout the supply chain. The adoption of biometric technologies, such as iris or fingerprint recognition, emerges as the solution to ensure compliance.
Consequences of non-compliance with data integrity in the pharmaceutical industry
Non-compliance with GMP regulations, particularly in critical factors such as data integrity and employee identification in manufacturing tasks, can lead to regulatory agencies issuing warning letters and even suspending manufacturing operations. How do you effectively address and prevent these consequences to ensure compliance?
Subscribe to our newsletter
Receive information of interest about biometrics for your sector
Subscribe to our newsletter
Receive information of interest about biometrics for your sector
Subscribe to our newsletter
Receive information of interest about biometrics for your sector
